Form 4: Balchem CFO Boosts Stake with Equity Awards

Balchem Corporation's EVP & CFO, Carl Martin Bengtsson, reported significant equity awards and option grants, alongside tax-related share disposals, under a pre-arranged 10b5-1 plan.

Summary

• Carl Martin Bengtsson, EVP & Chief Financial Officer of Balchem Corporation, acquired 3,610 shares of common stock as a restricted stock grant on February 11, 2026.
• An additional 4,718 shares of common stock vested on February 11, 2026, representing performance stock units for the 2023-2025 period, including 78 dividend equivalent shares.
• Bengtsson was granted 13,200 stock options with an exercise price of $178.68 on February 11, 2026, expiring on February 11, 2036.
• 2,416 shares were withheld on February 11, 2026, at a price of $178.68 to cover tax requirements upon the vesting of performance stock units.
• 302 shares were withheld on February 12, 2026, at a price of $177.49 to cover withholding taxes due upon the vesting of restricted shares granted on February 12, 2025.
• Following these transactions, Bengtsson directly owns 27,926 shares of common stock and 13,200 stock options, with an additional 1,086 shares held indirectly in a 401(k) Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it reflects ongoing executive compensation and alignment of interests through equity awards, which are standard and expected. The disposals are routine tax-related transactions.

Positives

• Acquisition of 3,610 shares of common stock as a restricted stock grant, indicating continued equity alignment with the company's performance.
• Vesting of 4,718 performance stock units, reflecting achievement of performance targets for the 2023-2025 period.
• Grant of 13,200 stock options, providing long-term incentive and potential for future value creation.

Negatives

• Disposal of 2,416 shares and 302 shares to cover tax obligations upon vesting of equity awards, which reduces direct share ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that equity compensation, including restricted stock, performance units, and stock options, is a standard practice across industries to align executive incentives with shareholder interests and retain key talent. The use of a Rule 10b5-1 plan for these transactions is also a common corporate governance practice to mitigate concerns about insider trading.

Related Party Transactions

• The transactions involve equity compensation granted by Balchem Corporation to its EVP & Chief Financial Officer, Carl Martin Bengtsson, which are considered related party dealings inherent to executive compensation.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value through equity ownership and long-term incentives. The tax-related sales are a common and expected part of equity compensation.
• Management: Carl Martin Bengtsson's compensation package is being executed, providing incentives for continued performance.

Next Steps

• Restricted stock will vest over a 3-year period (25% on the first anniversary, 25% on the second, 50% on the third).
• Stock options will vest over a 3-year period (20% Year 1, 40% Year 2, 40% Year 3).

Key Dates

Recommendation

The filing details routine executive compensation transactions, including equity awards and tax-related share disposals, executed under a pre-arranged 10b5-1 plan. These are expected events and do not signal a change in the company's fundamental outlook or the executive's discretionary view on the stock. Therefore, the filing itself does not warrant a change in investment recommendation, suggesting a 'hold' position based solely on this information.

Keywords

Balchem Corporation, BCPC, Form 4, Insider Trading, Equity Compensation, Restricted Stock, Performance Stock Units, Stock Options, Executive Compensation, Carl Martin Bengtsson, CFO